0
     

Report Added
Report already added
Colorectal Cancer Therapeutics Market - Global Outlook and Forecast 2022-2028

Colorectal Cancer Therapeutics Market - Global Outlook and Forecast 2022-2028

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time
This report contains market size and forecasts of Colorectal Cancer Therapeutics in Global, including the following market information:

Global Colorectal Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Colorectal Cancer Therapeutics market was valued at 12490 million in 2021 and is projected to reach US$ 17250 million by 2028, at a CAGR of 4.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnostics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Colorectal Cancer Therapeutics include Taiho Pharma, Merck KGaA, Amgen, Takeda, Roche, Eli Lilly, Sanofi, Regeneron and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Colorectal Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Colorectal Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Colorectal Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)
Diagnostics
Therapeutics
Global Colorectal Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Colorectal Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Research Institutions
Global Colorectal Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Colorectal Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Colorectal Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Colorectal Cancer Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Bristol-Myers Squib
Sumitomo Dainippon Pharma
Array BioPharma
Hutchison MediPharma
Jiangsu Hengrui Medicine
Jiangsu Chia-Tai Tianqing
Suzhou Zelgen Biopharmaceuticals
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Colorectal Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Colorectal Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Colorectal Cancer Therapeutics Overall Market Size
2.1 Global Colorectal Cancer Therapeutics Market Size: 2021 VS 2028
2.2 Global Colorectal Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Colorectal Cancer Therapeutics Players in Global Market
3.2 Top Global Colorectal Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Colorectal Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Colorectal Cancer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Colorectal Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Colorectal Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Colorectal Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Colorectal Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Colorectal Cancer Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Diagnostics
4.1.3 Therapeutics
4.2 By Type - Global Colorectal Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Colorectal Cancer Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Colorectal Cancer Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Colorectal Cancer Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Colorectal Cancer Therapeutics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Research Institutions
5.2 By Application - Global Colorectal Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Colorectal Cancer Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Colorectal Cancer Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Colorectal Cancer Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Colorectal Cancer Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Colorectal Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Colorectal Cancer Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Colorectal Cancer Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Colorectal Cancer Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Colorectal Cancer Therapeutics Revenue, 2017-2028
6.3.2 US Colorectal Cancer Therapeutics Market Size, 2017-2028
6.3.3 Canada Colorectal Cancer Therapeutics Market Size, 2017-2028
6.3.4 Mexico Colorectal Cancer Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Colorectal Cancer Therapeutics Revenue, 2017-2028
6.4.2 Germany Colorectal Cancer Therapeutics Market Size, 2017-2028
6.4.3 France Colorectal Cancer Therapeutics Market Size, 2017-2028
6.4.4 U.K. Colorectal Cancer Therapeutics Market Size, 2017-2028
6.4.5 Italy Colorectal Cancer Therapeutics Market Size, 2017-2028
6.4.6 Russia Colorectal Cancer Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Colorectal Cancer Therapeutics Market Size, 2017-2028
6.4.8 Benelux Colorectal Cancer Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Colorectal Cancer Therapeutics Revenue, 2017-2028
6.5.2 China Colorectal Cancer Therapeutics Market Size, 2017-2028
6.5.3 Japan Colorectal Cancer Therapeutics Market Size, 2017-2028
6.5.4 South Korea Colorectal Cancer Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Colorectal Cancer Therapeutics Market Size, 2017-2028
6.5.6 India Colorectal Cancer Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Colorectal Cancer Therapeutics Revenue, 2017-2028
6.6.2 Brazil Colorectal Cancer Therapeutics Market Size, 2017-2028
6.6.3 Argentina Colorectal Cancer Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Colorectal Cancer Therapeutics Revenue, 2017-2028
6.7.2 Turkey Colorectal Cancer Therapeutics Market Size, 2017-2028
6.7.3 Israel Colorectal Cancer Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Colorectal Cancer Therapeutics Market Size, 2017-2028
6.7.5 UAE Colorectal Cancer Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Taiho Pharma
7.1.1 Taiho Pharma Corporate Summary
7.1.2 Taiho Pharma Business Overview
7.1.3 Taiho Pharma Colorectal Cancer Therapeutics Major Product Offerings
7.1.4 Taiho Pharma Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Taiho Pharma Key News
7.2 Merck KGaA
7.2.1 Merck KGaA Corporate Summary
7.2.2 Merck KGaA Business Overview
7.2.3 Merck KGaA Colorectal Cancer Therapeutics Major Product Offerings
7.2.4 Merck KGaA Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Merck KGaA Key News
7.3 Amgen
7.3.1 Amgen Corporate Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Colorectal Cancer Therapeutics Major Product Offerings
7.3.4 Amgen Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Amgen Key News
7.4 Takeda
7.4.1 Takeda Corporate Summary
7.4.2 Takeda Business Overview
7.4.3 Takeda Colorectal Cancer Therapeutics Major Product Offerings
7.4.4 Takeda Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Takeda Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Colorectal Cancer Therapeutics Major Product Offerings
7.5.4 Roche Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
7.6 Eli Lilly
7.6.1 Eli Lilly Corporate Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Colorectal Cancer Therapeutics Major Product Offerings
7.6.4 Eli Lilly Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Eli Lilly Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Colorectal Cancer Therapeutics Major Product Offerings
7.7.4 Sanofi Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Sanofi Key News
7.8 Regeneron
7.8.1 Regeneron Corporate Summary
7.8.2 Regeneron Business Overview
7.8.3 Regeneron Colorectal Cancer Therapeutics Major Product Offerings
7.8.4 Regeneron Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Regeneron Key News
7.9 Bayer
7.9.1 Bayer Corporate Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Colorectal Cancer Therapeutics Major Product Offerings
7.9.4 Bayer Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Bayer Key News
7.10 Onyx
7.10.1 Onyx Corporate Summary
7.10.2 Onyx Business Overview
7.10.3 Onyx Colorectal Cancer Therapeutics Major Product Offerings
7.10.4 Onyx Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Onyx Key News
7.11 Bristol-Myers Squib
7.11.1 Bristol-Myers Squib Corporate Summary
7.11.2 Bristol-Myers Squib Business Overview
7.11.3 Bristol-Myers Squib Colorectal Cancer Therapeutics Major Product Offerings
7.11.4 Bristol-Myers Squib Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.11.5 Bristol-Myers Squib Key News
7.12 Sumitomo Dainippon Pharma
7.12.1 Sumitomo Dainippon Pharma Corporate Summary
7.12.2 Sumitomo Dainippon Pharma Business Overview
7.12.3 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Major Product Offerings
7.12.4 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.12.5 Sumitomo Dainippon Pharma Key News
7.13 Array BioPharma
7.13.1 Array BioPharma Corporate Summary
7.13.2 Array BioPharma Business Overview
7.13.3 Array BioPharma Colorectal Cancer Therapeutics Major Product Offerings
7.13.4 Array BioPharma Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.13.5 Array BioPharma Key News
7.14 Hutchison MediPharma
7.14.1 Hutchison MediPharma Corporate Summary
7.14.2 Hutchison MediPharma Business Overview
7.14.3 Hutchison MediPharma Colorectal Cancer Therapeutics Major Product Offerings
7.14.4 Hutchison MediPharma Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.14.5 Hutchison MediPharma Key News
7.15 Jiangsu Hengrui Medicine
7.15.1 Jiangsu Hengrui Medicine Corporate Summary
7.15.2 Jiangsu Hengrui Medicine Business Overview
7.15.3 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Major Product Offerings
7.15.4 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.15.5 Jiangsu Hengrui Medicine Key News
7.16 Jiangsu Chia-Tai Tianqing
7.16.1 Jiangsu Chia-Tai Tianqing Corporate Summary
7.16.2 Jiangsu Chia-Tai Tianqing Business Overview
7.16.3 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Major Product Offerings
7.16.4 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.16.5 Jiangsu Chia-Tai Tianqing Key News
7.17 Suzhou Zelgen Biopharmaceuticals
7.17.1 Suzhou Zelgen Biopharmaceuticals Corporate Summary
7.17.2 Suzhou Zelgen Biopharmaceuticals Business Overview
7.17.3 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Major Product Offerings
7.17.4 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Revenue in Global Market (2017-2022)
7.17.5 Suzhou Zelgen Biopharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Colorectal Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Colorectal Cancer Therapeutics Market Drivers in Global Market
Table 3. Colorectal Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Colorectal Cancer Therapeutics in Global Market
Table 5. Top Colorectal Cancer Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Colorectal Cancer Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Colorectal Cancer Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Colorectal Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Colorectal Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Colorectal Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Colorectal Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Colorectal Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Colorectal Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Colorectal Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Colorectal Cancer Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Colorectal Cancer Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Taiho Pharma Corporate Summary
Table 31. Taiho Pharma Colorectal Cancer Therapeutics Product Offerings
Table 32. Taiho Pharma Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Merck KGaA Corporate Summary
Table 34. Merck KGaA Colorectal Cancer Therapeutics Product Offerings
Table 35. Merck KGaA Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Amgen Corporate Summary
Table 37. Amgen Colorectal Cancer Therapeutics Product Offerings
Table 38. Amgen Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Takeda Corporate Summary
Table 40. Takeda Colorectal Cancer Therapeutics Product Offerings
Table 41. Takeda Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Colorectal Cancer Therapeutics Product Offerings
Table 44. Roche Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Eli Lilly Corporate Summary
Table 46. Eli Lilly Colorectal Cancer Therapeutics Product Offerings
Table 47. Eli Lilly Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Colorectal Cancer Therapeutics Product Offerings
Table 50. Sanofi Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Regeneron Corporate Summary
Table 52. Regeneron Colorectal Cancer Therapeutics Product Offerings
Table 53. Regeneron Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Bayer Corporate Summary
Table 55. Bayer Colorectal Cancer Therapeutics Product Offerings
Table 56. Bayer Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Onyx Corporate Summary
Table 58. Onyx Colorectal Cancer Therapeutics Product Offerings
Table 59. Onyx Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Bristol-Myers Squib Corporate Summary
Table 61. Bristol-Myers Squib Colorectal Cancer Therapeutics Product Offerings
Table 62. Bristol-Myers Squib Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Sumitomo Dainippon Pharma Corporate Summary
Table 64. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Product Offerings
Table 65. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. Array BioPharma Corporate Summary
Table 67. Array BioPharma Colorectal Cancer Therapeutics Product Offerings
Table 68. Array BioPharma Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. Hutchison MediPharma Corporate Summary
Table 70. Hutchison MediPharma Colorectal Cancer Therapeutics Product Offerings
Table 71. Hutchison MediPharma Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 72. Jiangsu Hengrui Medicine Corporate Summary
Table 73. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Product Offerings
Table 74. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 75. Jiangsu Chia-Tai Tianqing Corporate Summary
Table 76. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Product Offerings
Table 77. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 78. Suzhou Zelgen Biopharmaceuticals Corporate Summary
Table 79. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Product Offerings
Table 80. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Colorectal Cancer Therapeutics Segment by Type in 2021
Figure 2. Colorectal Cancer Therapeutics Segment by Application in 2021
Figure 3. Global Colorectal Cancer Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Colorectal Cancer Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Colorectal Cancer Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Colorectal Cancer Therapeutics Revenue in 2021
Figure 8. By Type - Global Colorectal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Colorectal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Colorectal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Colorectal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Colorectal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Colorectal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Colorectal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Colorectal Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Colorectal Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Taiho Pharma Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck KGaA Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Amgen Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Takeda Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eli Lilly Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Regeneron Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bayer Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Onyx Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bristol-Myers Squib Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Array BioPharma Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Hutchison MediPharma Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Colorectal Cancer Therapeutics Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW